Complete Acid Ceramidase ablation prevents cancer-initiating cell formation in melanoma cells

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Lai, Michele ^a,b,c,d   Realini, Natalia ^a   La Ferla, Marco ^b   Passalacqua, Ilaria ^c   Matteoli, Giulia ^c   Ganesan, Anand ^e   Pistello, Mauro ^c   Mazzanti, Chiara Maria ^b   Piomelli, Daniele ^d  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b Pisa Science Foundation   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID CERAMIDASE; ASAH1 PROTEIN, HUMAN; CERAMIDE; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ANALOGS AND DERIVATIVES; CELL AGING; CELL PROLIFERATION; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; ENZYMOLOGY; GENE KNOCKOUT; GENETICS; HUMAN; MELANOCYTE; METABOLISM; TUMOR CELL LINE;

ACID CERAMIDASE; CELL LINE, TUMOR; CELL PROLIFERATION; CELLULAR SENESCENCE; CERAMIDES; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-ASSOCIATED PROTEIN 9; GENE KNOCKOUT TECHNIQUES; HUMANS; LYSOPHOSPHOLIPIDS; MELANOCYTES; SPHINGOSINE;

EID: 85027227639     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-07606-w     Document Type: Article

References (59)

1. Mao, C. & Obeid, L. M. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1- phosphate. Biochim Biophys Acta 1781, 424-434 (2008).
2. Alphonse, G. et al. Ceramide induces activation of the mitochondrial/caspases pathway in Jurkat and SCC61 cells sensitive to gamma-radiation but activation of this sequence is defective in radioresistant SQ20B cells. Int J Radiat Biol 78, 821-835 (2002).
3. Abuhusain, H. J. et al. A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis. J Biol Chem 288, 37355-37364 (2013).
4. Beckham, T. H. et al. Acid ceramidase induces sphingosine kinase 1/S1P receptor 2-mediated activation of oncogenic Akt signaling. Oncogenesis 2, e49 (2013).
5. Bedia, C., Casas, J., Andrieu-Abadie, N., Fabrias, G. & Levade, T. Acid ceramidase expression modulates the sensitivity of A375 melanoma cells to dacarbazine. J Biol Chem 286, 28200-28209 (2011).
6. Beckham, T. H. et al. Acid ceramidase promotes nuclear export of PTEN through sphingosine 1-phosphate mediated Akt signaling. PLoS One 8, e76593 (2013).
7. Saad, A. F. et al. The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy. Cancer Biol Ther 6, 1455-1460 (2007).
8. Realini, N. et al. Acid Ceramidase in Melanoma: Expression, Localization and Effects of Pharmacological Inhibition. J Biol Chem (2015).
9. Seelan, R. S. et al. Human acid ceramidase is overexpressed but not mutated in prostate cancer. Genes Chromosomes Cancer 29, 137-146 (2000).
10. Park, J. H. & Schuchman, E. H. Acid ceramidase and human disease. Biochim Biophys Acta 1758, 2133-2138 (2006).
11. Zeidan, Y. H. et al. Molecular targeting of acid ceramidase: implications to cancer therapy. Curr Drug Targets 9, 653-661 (2008).
12. Hajj, C., Becker-Flegler, K. A. & Haimovitz-Friedman, A. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways. Biol Chem 396, 669-679 (2015).
13. Galadari, S., Rahman, A., Pallichankandy, S. & Thayyullathil, F. Tumor suppressive functions of ceramide: evidence and mechanisms. Apoptosis 20, 689-711 (2015).
14. Dany, M. & Ogretmen, B. Ceramide induced mitophagy and tumor suppression. Biochim Biophys Acta 1853, 2834-2845 (2015).
15. Mahdy, A. E. et al. Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer. Mol Ther 17, 430-438 (2009).
16. Gouaze-Andersson, V. et al. Inhibition of acid ceramidase by a 2-substituted aminoethanol amide synergistically sensitizes prostate cancer cells to N-(4-hydroxyphenyl) retinamide. Prostate 71, 1064-1073 (2011).
17. Elojeimy, S. et al. Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy. Mol Ther 15, 1259-1263 (2007).
18. Morales, A. et al. Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo. Oncogene 26, 905-916 (2007).
19. Realini, N. et al. Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity. Sci Rep 3, 1035 (2013).
20. Berndt, N., Patel, R., Yang, H., Balasis, M. E. & Sebti, S. M. Akt2 and acid ceramidase cooperate to induce cell invasion and resistance to apoptosis. Cell Cycle 12, 2024-2032 (2013).
21. Feng, H. et al. EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis. J Clin Invest 124, 3741-3756 (2014).
22. Venable, M. E., Lee, J. Y., Smyth, M. J., Bielawska, A. & Obeid, L. M. Role of ceramide in cellular senescence. J Biol Chem 270, 30701-30708 (1995).
23. Bieberich, E. Ceramide signaling in cancer and stem cells. Future Lipidol 3, 273-300 (2008).
24. Eliyahu, E., Park, J. H., Shtraizent, N., He, X. & Schuchman, E. H. Acid ceramidase is a novel factor required for early embryo survival. FASEB J 21, 1403-1409 (2007).
25. Hannun, Y. A. & Obeid, L. M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9, 139-150 (2008).
26. Santini, R. et al. SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells. Oncogene 33, 4697-4708 (2014).
27. Chen, X. et al. Dual sgRNA-directed gene knockout using CRISPR/Cas9 technology in Caenorhabditis elegans. Sci Rep 4, 7581 (2014).
28. Lai, M. et al. Gene editing of DNAH11 restores normal cilia motility in primary ciliary dyskinesia. J Med Genet 53, 242-249 (2016).
29. Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8, 2281-2308 (2013).
30. Chu, V. T. et al. Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat Biotechnol 33, 543-548 (2015).
31. Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911-917 (1959).
32. Basit, A., Piomelli, D. & Armirotti, A. Rapid evaluation of 25 key sphingolipids and phosphosphingolipids in human plasma by LCMS/ MS. Anal Bioanal Chem 407, 5189-5198 (2015).
33. Obeid, L. M., Linardic, C. M., Karolak, L. A. & Hannun, Y. A. Programmed cell death induced by ceramide. Science 259, 1769-1771 (1993).
34. Venable, M. E. & Yin, X. Ceramide induces endothelial cell senescence. Cell Biochem Funct 27, 547-551 (2009).
35. Wellbrock, C. et al. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS One 3, e2734 (2008).
36. Bartek, J. & Lukas, J. Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol 13, 738-747 (2001).
37. Astarita, G. et al. Methamphetamine accelerates cellular senescence through stimulation of de novo ceramide biosynthesis. PLoS One 10, e0116961 (2015).
38. Kim, R., Minami, K., Nishimoto, N. & Toge, T. Enhancement of antitumor effect by intratumoral administration of bax gene in combination with anticancer drugs in gastric cancer. Int J Oncol 18, 363-367 (2001).
39. Lee, N., Barthel, S. R. & Schatton, T. Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking? Lab Invest 94, 13-30 (2014).
40. Ozsvari, B., Lamb, R. & Lisanti, M. P. Repurposing of FDA-approved drugs against cancer - focus on metastasis. Aging (Albany NY) 8, 567-568 (2016).
41. Potterf, S. B., Furumura, M., Dunn, K. J., Arnheiter, H. & Pavan, W. J. Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum Genet 107, 1-6 (2000).
42. Boiko, A. D. et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466, 133-137 (2010).
43. Camacho, L. et al. Acid ceramidase as a therapeutic target in metastatic prostate cancer. J Lipid Res 54, 1207-1220 (2013).
44. Cheng, J. C. et al. Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse. The Journal of clinical investigation 123, 4344-4358 (2013).
45. Li, C. M. et al. Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes. Genomics 79, 218-224 (2002).
46. Roh, J. L., Park, J. Y., Kim, E. H. & Jang, H. J. Targeting acid ceramidase sensitises head and neck cancer to cisplatin. Eur J Cancer 52, 163-172 (2016).
47. Stratford, S., Hoehn, K. L., Liu, F. & Summers, S. A. Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B. J Biol Chem 279, 36608-36615 (2004).
48. Sultan, I. et al. Regulation of the sphingosine-recycling pathway for ceramide generation by oxidative stress, and its role in controlling c-Myc/Max function. Biochem J 393, 513-521 (2006).
49. Turner, L. S. et al. Autophagy is increased in prostate cancer cells overexpressing acid ceramidase and enhances resistance to C6 ceramide. Prostate Cancer Prostatic Dis 14, 30-37 (2011).
50. Teni, T., Pawar, S., Sanghvi, V. & Saranath, D. Expression of bcl-2 and bax in chewing tobacco-induced oral cancers and oral lesions from India. Pathol Oncol Res 8, 109-114 (2002).
51. Heise, T. et al. The La protein counteracts cisplatin-induced cell death by stimulating protein synthesis of anti-apoptotic factor Bcl2. Oncotarget (2016).
52. Borghi, A., Verstrepen, L. & Beyaert, R. TRAF2 multitasking in TNF receptor-induced signaling to NF-kappaB, MAP kinases and cell death. Biochem Pharmacol (2016).
53. Zhang, L. et al. TRAF2 exerts opposing effects on basal and TNFalpha-induced activation of the classic IKK complex in hematopoietic cells in mice. J Cell Sci 129, 1455-1467 (2016).
54. Lee, B. Y. et al. Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell 5, 187-195 (2006).
55. Levy, C., Khaled, M. & Fisher, D. E. MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 12, 406-414 (2006).
56. Giuliano, S. et al. Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas. Cancer Res 70, 3813-3822 (2010).
57. Bondurand, N. et al. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum Mol Genet 9, 1907-1917 (2000).
58. Luo, Y. et al. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells 30, 2100-2113 (2012).
59. Shao, C. et al. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway. Clin Cancer Res 20, 4154-4166 (2014).